Experimental Drug Breaks Record For Weight Loss in Latest Clinical Trial Results

The U.S. Food and Drug Administration today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease.

Interferon therapy shows striking results against COVID-19

A new weight loss drug could be used to prevent obesity. Will it work?